Zusammenfassung
Früherkennung in der Onkologie hat zum Ziel, eine onkologische Erkrankung so frühzeitig zu erkennen, dass sie noch dauerhaft geheilt werden kann. Früherkennung des Mammakarzinoms wendet sich an apparent gesunde (asymptomatische) Frauen, von denen nur eine geringe Zahl unerkannt erkrankt ist.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Andersson I, Sigfusson BF (1987) Screening for breast cancer in Malmo: a randomized trial. Recent Results Cancer Res 105:62–66
Ballard-Barbash R, Klabunde C, Paci E et al. (1999) Breast cancer screening in 21 countries: delivery of services, notification of results and outcomes ascertainment. Eur J Cancer Prev 8(5): 417–426
Baxter N (2001) Preventive health care, 2001 update: should women be routinely taught breast self-examination to screen for breast cancer? CMAJ 164(13): 1837–1846
Beam CA, Sullivan DC, Layde PM (1996) Effect of human variability on independent double reading in screening mammography. Acad Radiol Nov 3(11): 891–897
Berg WA (2003) Rationale for a trial of screening breast ultrasound: American College of Radiology Imaging Network (ACRIN) 6666. AJR Am J Roentgenol 180(5): 1225–1228
Bjurstam N, Bjorneld L, Warwick J et al. (2003) The Gothenburg Breast Screening Trial. Cancer 97(10): 2387–2396
Blanks RG, Wallis MG, Moss SM (1998) A comparison of cancer detection rates achieved by breast cancer screening programmes by number of readers, for one and two view mammography: results from the UK National Health Service breast screening programme. J Med Screen 5(4): 195–201
Botha JL, Bray F, Sankila R, Parkin DM (2003) Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 39(12): 1718–1729
Buchberger W, Niehoff A, Obrist P, Koekkoek-Doll P, Dunser M (2000) Clinically and mammographically occult breast lesions: detection and classification with high-resolution sonography. Semin Ultrasound CT MR 21(4): 325–336
Evans AJ, Pinder SE, Ellis IO, Wilson AR (2001) Screen detected ductal carcinoma in situ (DCIS): overdiagnosis or an obligate precursor of invasive disease? J Med Screen 8(3): 149–151
Fletcher SW (1997) Breast cancer screening among women in their forties: an overview of the issues. J Natl Cancer Inst Monogr 22:5–9
Gordon PB, Goldenberg SL (1995) Malignant breast masses detected only by ultrasound. A retrospective review. Cancer 76(4): 626–630
Hellquist BN, Duffy SW, Abdsaleh S, Björneld L, Bordas P, Tabar L, Vitak B, Zackrisson S, Nyström L, Jonsson H (2010) Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer 117(4): 714–722
Heywang-Köbrunner SH, Bick U, Bradley WG jr et al. (2001) International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions. Eur Radiol 11(4): 531–546
Junkermann H, Becker N, Peitgen HO (2001) Konzept und Durchführung der Modellprojekte in Deutschland. Radiologe 41(4): 328–336
Knopp MV, Weiss E, Sinn HP et al. (1999) Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 10(3): 260–266
Kolb TM, Lichy J, Newhouse JH (1998) Occult cancer in women with dense breasts: Detection with screening ultrasounddiagnostic yield and tumor characteristics. Radiology 207:191–199
Kriege M, Brekelmans CT, Boetes C et al. (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351(5): 427–437
Kuhl C, Weigel S, Schrading S, Arand B, Bieling H, König R, Tombach B, Leutner C, Rieber-Brambs A, Nordhoff D, Heindel W, Reiser M, Schild HH (2010) Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol 28(9): 1450–1457
Kuhl CK, Schmutzler RK, Leutner CC et al. (2000) Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 215(1): 267–279
Law J, Faulkner K (2001) Cancers detected and induced, and associated risk and benefit, in a breast screening programme. Br J Radiol 74(888): 1121–1127
Law J, Faulkner K (2002) Concerning the relationship between benefit and radiation risk, and cancers detected and induced, in a breast screening programme. Br J Radiol 75(896): 678–684
Mandelblatt J, Saha S, Teutsch S et al. (2003) The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 139(10): 835–842
Moss S (2004) Should women under 50 be screened for breast cancer? Br J Cancer 91(3): 413–417
Paci E, Warwick J, Falini P, Duffy SW (2004) Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern? J Med Screen 11(1): 23–27
Perry N, Broeders M, Wolf C de, Törnberg S (eds) (2003) European guidelines for quality assurance in breast cancer screening, 3rd edn. European C, Luxembourg
Rosselli DT, Paci E (1993) Mammography and overdiagnosis. Ann Oncol 4(1): 9–10
Sardanelli F, Podo F, Santoro F et al.; for the High Breast Cancer Risk Italian 1 (HIBCRIT-1) Study. Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results. Invest Radiol 44(2): 94–105
Semiglazov VF, Manikhas AG, Moiseenko VM et al. (2003) Results of a prospective randomized investigation [Russia (St.Petersburg)/WHO] to evaluate the significance of selfexamination for the early detection of breast cancer. Vopr Onkol 49(4): 434–441
Tabar L, Fagerberg CJ, Gad A et al. (1985) Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1(8433): 829–832
Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O (1992) Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am Jan 30(1): 187–210
Teh W, Wilson AR (1998) The role of ultrasound in breast cancer screening. A consensus statement by the European Group for Breast Cancer Screening. Eur J Cancer 34(4): 449–450
Thomas DB, Gao DL, Ray RM et al. (2002) Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst 94(19): 1445–1457
Vainio H, Bianchini F (2002) IARC Handbooks of Cancer Prevention. Vol. 7: Breast cancer screening. lARCPress, Lyon
Schoor G van, Moss SM, Otten JD, Donders R, Paap E, den Heeten GJ, Holland R, Broeders MJ, Verbeek AL (2010) Effective biennial mammographic screening in women aged 40–49. Eur J Cancer 46(18): 3137–3140
Zahl PH, Strand BH, Maehlen J (2004) Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. Br Med J 328(7445): 921–924
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Junkermann, H. (2013). Früherkennung des Mammakarzinoms. In: Wacker, J., Sillem, M., Bastert, G., Beckmann, M. (eds) Therapiehandbuch Gynäkologie und Geburtshilfe. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-30189-6_29
Download citation
DOI: https://doi.org/10.1007/978-3-642-30189-6_29
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-30188-9
Online ISBN: 978-3-642-30189-6
eBook Packages: Medicine (German Language)